Friday 3 January 2020

Global Excipients Market Size, Share, Revenue, Growth and Forecast Report, 2025

The global Excipients Market size is expected to reach USD 6.9 billion by 2025, expanding at a CAGR of 6.02% from 2017 to 2025, according to a new report by Grand View Research, Inc. Globally increasing reach of generic medicines has been a major factor driving market growth. In addition, rising demand for newer excipients owing to the advantages of drug delivery and stability has led to the growth of the market. 

Excipients are essential components for the improvement of overall pharmaceutical activity and performance, both of which directly impact the characteristics of pharmaceutical formulations. An excipient in the right proportion can improve the shelf life and bioavailability of a formulation. These can also be used in drug delivery mechanisms such as sustained release and rapid release drugs.

Excipients Market


Polymers were the largest product category in 2016 and are expected to maintain a comparatively moderate growth rate over the forecast period. Microcrystalline cellulose was the leading polymer in this category, accounting for a share of over 26.0% in 2016.

Sugars are expected to observe the fastest growth over the  coming years, exhibiting an estimated CAGR of 5.1% from 2017 to 2025. Sugars can play an instrumental role in increasing solubility, taste masking, dissolution, and drug delivery, which can drive its market.


Further key findings from the report suggest:
  • The global excipients demand exceeded 600,000 tons in 2016 and is expected to grow at a moderate rate from 2017 to 2025
  • Owing to high market demand, polymer excipients accounted for the largest revenue share in 2016 and the segment can be anticipated to dominate the market for the coming years as well
  • The global demand for sugars excipients was valued at over USD 1 billion in 2016 and is anticipated to witness significant growth over the coming years
  • The Europe polymers market was pegged at 74,000 tons in 2015 and is estimated to reach a total volume of over 100,000 tons by 2025
  • The market in Asia Pacific is projected to witness substantial growth over the course of the forecast period thanks to several development projects undertaken across major economies, especially in newer excipients markets. The regional market is expected to register a CAGR of 6.63% from 2017 to 2025
  • Key market participants include Eastman Chemical Corporation; P&G Chemicals; Avantor Performance Materials, LLC; Huntsman Corporation; BASF SE; Ashland Inc.; FMC Corporation; Roquette; Colorcon Inc.; Lubrizol Corporation; Valeant; JRS Pharma; Shin-Etsu Chemical Co., Ltd.; DFE Pharma; and Finar Limited.
 About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James

Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email:
sales@grandviewresearch.com
For More Information:
https://www.grandviewresearch.com


No comments:

Post a Comment

Insulin Delivery Devices Market To Reach $28.06 Billion By 2030

  The global  Insulin Delivery Devices Market  size was estimated at USD 28.06 billion in 2030 and is expected to grow at a CAGR of 7.89% fr...